X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (4125) 4125
Publication (310) 310
Book Review (39) 39
Book / eBook (36) 36
Book Chapter (14) 14
Dissertation (6) 6
Conference Proceeding (1) 1
Government Document (1) 1
Magazine Article (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (3782) 3782
female (2113) 2113
male (2018) 2018
index medicus (1794) 1794
middle aged (1508) 1508
adult (1507) 1507
pathology (1459) 1459
immunohistochemistry (1342) 1342
oncology (1207) 1207
soft tissue neoplasms - metabolism (1201) 1201
soft tissue neoplasms - pathology (1176) 1176
aged (1139) 1139
tumors (892) 892
sarcoma (808) 808
cancer (755) 755
adolescent (722) 722
animals (657) 657
biomarkers, tumor - metabolism (623) 623
diagnosis, differential (564) 564
soft-tissue sarcomas (561) 561
expression (560) 560
child (559) 559
aged, 80 and over (492) 492
prognosis (472) 472
soft-tissue (472) 472
surgery (466) 466
sarcoma - pathology (444) 444
sarcoma - metabolism (443) 443
soft tissue neoplasms - genetics (415) 415
diagnosis (372) 372
soft tissue neoplasms - diagnosis (350) 350
soft-tissue sarcoma (346) 346
mice (324) 324
analysis (319) 319
metastasis (315) 315
young adult (310) 310
chemotherapy (309) 309
child, preschool (296) 296
cell line, tumor (293) 293
cell biology (286) 286
treatment outcome (271) 271
gene expression (266) 266
research (266) 266
medicine & public health (249) 249
biomarkers, tumor - analysis (247) 247
bone neoplasms - metabolism (246) 246
radiology, nuclear medicine & medical imaging (241) 241
soft tissue neoplasms - surgery (237) 237
bone neoplasms - pathology (228) 228
retrospective studies (223) 223
soft tissue sarcoma (221) 221
proteins (219) 219
gene expression regulation, neoplastic (217) 217
infant (209) 209
research article (209) 209
medicine (204) 204
care and treatment (201) 201
immunoenzyme techniques (197) 197
carcinoma (196) 196
soft tissue neoplasms - drug therapy (196) 196
apoptosis (195) 195
bone (192) 192
mutation (192) 192
sarcoma - genetics (192) 192
gene (191) 191
synovial sarcoma (191) 191
magnetic resonance imaging (184) 184
skin neoplasms - pathology (184) 184
neoplasm proteins - metabolism (181) 181
sarcoma - drug therapy (181) 181
neoplasms (179) 179
breast-cancer (178) 178
cells (178) 178
reverse transcriptase polymerase chain reaction (178) 178
article (172) 172
soft-tissue tumors (172) 172
skin neoplasms - metabolism (171) 171
in situ hybridization, fluorescence (165) 165
dermatology (160) 160
follow-up studies (159) 159
health aspects (159) 159
tumor (158) 158
soft tissue neoplasms - diagnostic imaging (156) 156
osteosarcoma (154) 154
differentiation (153) 153
pediatrics (151) 151
biology (147) 147
medicine, research & experimental (147) 147
p53 (147) 147
soft tissue (145) 145
science (144) 144
biomarkers, tumor - genetics (140) 140
medical laboratory technology (140) 140
antineoplastic agents - therapeutic use (138) 138
multidisciplinary sciences (138) 138
neoplasms - metabolism (138) 138
tomography, x-ray computed (136) 136
genes (135) 135
oncogene proteins, fusion - genetics (135) 135
biopsy (133) 133
more...
Library Location Library Location
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (4018) 4018
Chinese (74) 74
German (30) 30
Russian (14) 14
Japanese (13) 13
Spanish (9) 9
French (4) 4
Italian (3) 3
Polish (3) 3
Bulgarian (1) 1
Korean (1) 1
Portuguese (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


American Journal of Surgical Pathology, ISSN 0147-5185, 10/2011, Volume 35, Issue 10, pp. e47 - e63
Significant progress has been made in understanding the molecular genetic alterations involved in sarcomagenesis. Cytogenetic and molecular studies have... 
malignant rhabdoid tumor | SMARCB1 | epithelioid sarcoma | schwannomatosis | SNF5 | soft tissue tumors | renal medullarycarcinoma | INI1 | SURGERY | NERVE SHEATH TUMOR | EXTRASKELETAL MYXOID CHONDROSARCOMA | PATHOLOGY | SOFT-TISSUE TUMORS | ROUND-CELL TUMOR | renal medullary carcinoma | DIFFERENTIATED SYNOVIAL SARCOMA | ATYPICAL TERATOID/RHABDOID TUMOR | OF-THE-LITERATURE | NATIONAL-WILMS-TUMOR | Myoepithelioma - metabolism | Kidney Neoplasms - genetics | Soft Tissue Neoplasms - diagnosis | Humans | Transcription Factors - deficiency | Carcinoma, Medullary - diagnosis | Carcinoma, Medullary - metabolism | Kidney Neoplasms - metabolism | DNA-Binding Proteins - deficiency | Kidney Neoplasms - diagnosis | DNA-Binding Proteins - metabolism | SMARCB1 Protein | Biomarkers, Tumor - metabolism | Sarcoma - diagnosis | Cytogenetic Analysis | Rhabdoid Tumor - metabolism | Sarcoma - genetics | Soft Tissue Neoplasms - genetics | Epithelioid Cells - pathology | Myoepithelioma - diagnosis | Chondrosarcoma - diagnosis | Chromosomal Proteins, Non-Histone - metabolism | Carcinoma, Medullary - genetics | Nerve Sheath Neoplasms - diagnosis | Soft Tissue Neoplasms - metabolism | Nerve Sheath Neoplasms - metabolism | Transcription Factors - genetics | DNA-Binding Proteins - genetics | Chromosomal Proteins, Non-Histone - deficiency | Chromosomal Proteins, Non-Histone - genetics | Epithelioid Cells - metabolism | Immunohistochemistry - methods | Sarcoma - metabolism | Transcription Factors - metabolism | Rhabdoid Tumor - genetics | Rhabdoid Tumor - diagnosis
Journal Article
Modern Pathology, ISSN 0893-3952, 2011, Volume 24, Issue 1, pp. 82 - 89
Journal Article
PLoS ONE, ISSN 1932-6203, 11/2011, Volume 6, Issue 11, p. e27970
Background: Although androgens are depleted in castration resistant prostate cancer (CRPC), metastases still express nuclear androgen receptor (AR) and... 
STEROIDOGENESIS | THERAPY | TESTOSTERONE | EPIDERMAL-GROWTH-FACTOR | BIOLOGY | GENE-EXPRESSION | FACTOR-I | BONE | CELL-LINES | SPLICE VARIANTS | PROGRESSION | Neoplasms, Hormone-Dependent - metabolism | Prostatic Neoplasms - metabolism | Prostatic Hyperplasia - pathology | Prognosis | Alternative Splicing | Humans | Middle Aged | Receptors, Androgen - metabolism | Gene Expression Regulation, Neoplastic | Bone Neoplasms - secondary | Male | Immunoenzyme Techniques | Prostate - metabolism | Bone Neoplasms - metabolism | Neoplasms, Hormone-Dependent - genetics | Prostate - pathology | Prostatic Neoplasms - genetics | Castration | Aged, 80 and over | Adult | Bone Neoplasms - genetics | Real-Time Polymerase Chain Reaction | Soft Tissue Neoplasms - genetics | Prostatic Neoplasms - pathology | Soft Tissue Neoplasms - secondary | RNA, Messenger - genetics | Soft Tissue Neoplasms - metabolism | Reverse Transcriptase Polymerase Chain Reaction | Prostatic Hyperplasia - genetics | Blotting, Western | Prostatic Hyperplasia - metabolism | Receptors, Androgen - genetics | Neoplasms, Hormone-Dependent - pathology | Cell Line, Tumor | Aged | Proteins | Viral antibodies | Antibodies | Androgens | Metastasis | Prostate cancer | Alternative splicing | Phosphorylation | Staining | Kinases | Tissues | Urology | Metastases | Angiogenesis | Xenografts | Localization | Medical research | Lymphatic system | Immunoglobulins | Review boards | C-Terminus | Gene expression | Polymerase chain reaction | Chemotherapy | Ligands | Immunoreactivity | Prostate | Cancer
Journal Article
Journal of Clinical Oncology, ISSN 0732-183X, 02/2010, Volume 28, Issue 6, pp. 976 - 983
Purpose To evaluate trastuzumab (H) and docetaxel (T) with or without capecitabine (X) as first-line combination therapy for human epidermal growth factor... 
SURVIVAL | COMBINATIONS | MULTICENTER | ONCOGENE | AMPLIFICATION | EFFICACY | ONCOLOGY | SAFETY | PRETREATED PATIENTS | ANTIBODY | PACLITAXEL | Prognosis | Receptor, ErbB-2 - genetics | Capecitabine | Humans | Middle Aged | Receptor, ErbB-2 - metabolism | Bone Neoplasms - secondary | Soft Tissue Neoplasms - drug therapy | Bone Neoplasms - metabolism | Breast Neoplasms - metabolism | Feasibility Studies | Young Adult | Antibodies, Monoclonal, Humanized | Fluorouracil - administration & dosage | Aged, 80 and over | Adult | Female | Bone Neoplasms - drug therapy | Liver Neoplasms - secondary | Fluorouracil - analogs & derivatives | Soft Tissue Neoplasms - secondary | Deoxycytidine - administration & dosage | Liver Neoplasms - drug therapy | Soft Tissue Neoplasms - metabolism | In Situ Hybridization, Fluorescence | Survival Rate | Treatment Outcome | Breast Neoplasms - drug therapy | Taxoids - administration & dosage | International Agencies | Antibodies, Monoclonal - administration & dosage | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Breast Neoplasms - pathology | Liver Neoplasms - metabolism | Aged | Neoplasm Staging | Deoxycytidine - analogs & derivatives | Trastuzumab | Liver Neoplasms | Breast Neoplasms | Life Sciences | Immunology | Taxoids | Fluorouracil | Antineoplastic Combined Chemotherapy Protocols | Antibodies, Monoclonal | Bone Neoplasms | Receptor, erbB-2 | Deoxycytidine | Soft Tissue Neoplasms
Journal Article
Lancet Oncology, The, ISSN 1470-2045, 2015, Volume 16, Issue 8, pp. 949 - 956
Summary Background Diffuse-type tenosynovial giant cell tumour (dt-GCT) of the soft tissue (alternatively known as pigmented villonodular synovitis), an orphan... 
Hematology, Oncology and Palliative Medicine | PIGMENTED VILLONODULAR SYNOVITIS | DIAGNOSIS | THERAPY | EFFICACY | ONCOLOGY | PERIORBITAL EDEMA SECONDARY | MACROPHAGES | RECEPTOR | ANTIBODY | ARTHRITIS | IMATINIB MESYLATE | Receptor, Macrophage Colony-Stimulating Factor - antagonists & inhibitors | Receptor, Macrophage Colony-Stimulating Factor - immunology | Giant Cell Tumors - immunology | Humans | Middle Aged | Antibodies, Monoclonal - adverse effects | Giant Cell Tumors - pathology | Soft Tissue Neoplasms - drug therapy | Male | Antineoplastic Agents - administration & dosage | Giant Cell Tumors - metabolism | Receptor, Macrophage Colony-Stimulating Factor - metabolism | Synovitis, Pigmented Villonodular - drug therapy | Synovitis, Pigmented Villonodular - pathology | Soft Tissue Neoplasms - immunology | Young Adult | Time Factors | Antineoplastic Agents - adverse effects | Aged, 80 and over | Adult | Female | Drug Administration Schedule | Soft Tissue Neoplasms - metabolism | Synovitis, Pigmented Villonodular - metabolism | Treatment Outcome | Synovitis, Pigmented Villonodular - immunology | Giant Cell Tumors - drug therapy | Signal Transduction - drug effects | Antibodies, Monoclonal - administration & dosage | Adolescent | Soft Tissue Neoplasms - pathology | Aged | Infusions, Intravenous | Monoclonal antibodies | Macrophage colony stimulating factor | Tumors
Journal Article
Journal Article
Histopathology, ISSN 0309-0167, 07/2013, Volume 63, Issue 1, pp. 36 - 49
Journal Article